Allard B, Beavis PA, Darcy PK, Stagg J (2016) Immunosuppressive activities of adenosine in cancer. Curr Opin Pharmacol 29:7–16

Article  CAS  PubMed  Google Scholar 

Allard B, Allard D, Buisseret L, Stagg J (2020) The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol 17(10):611–629

Article  CAS  PubMed  Google Scholar 

Al-Shar’i NA, Al-Balas QA (2019) Molecular dynamics simulations of adenosine receptors: advances, applications and trends. Curr Pharm des 25(7):783–816

Article  CAS  PubMed  Google Scholar 

Baba Y, Baba H (2018) Gene-expression signature may be useful for the prediction of lymph node metastasis in esophageal cancer. Ann Transl Med 6(11).

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 68(6):394–424

Article  Google Scholar 

Burnstock G (2018) The therapeutic potential of purinergic signalling. Biochem Pharmacol 151:157–165

Article  CAS  PubMed  Google Scholar 

Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J (2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 188(1):198–205

Article  CAS  PubMed  Google Scholar 

Chen J-F, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets—what are the challenges? Nat Rev Drug Discovery 12(4):265–286

Article  CAS  PubMed  Google Scholar 

Choi MS, Moon SM, Lee SA, Park BR, Kim JS, Kim DK, Kim YH, Kim CS (2018) Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells. Oncol Lett 15(5):6489–6496

PubMed  PubMed Central  Google Scholar 

Dubey RK, Gillespie DG, Jackson EK (2002) A2B adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 39(2):530–535

Article  CAS  PubMed  Google Scholar 

Dziedzic K, Węgrzyn P, Gałęzowski M, Bońkowska M, Grycuk K, Satała G et al (2021) Release of adenosine-induced immunosuppression: comprehensive characterization of dual A2A/A2B receptor antagonist. Int Immunopharmacol 96:107645

Article  CAS  PubMed  Google Scholar 

Farhood B, Geraily G, Alizadeh A (2018) Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health 47(3):309

PubMed  PubMed Central  Google Scholar 

Fredholm BB, Ijzerman AP, Jacobson KA, Linden J, Müller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update. Pharmacol Rev 63(1):1–34

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gariboldi V, Vairo D, Guieu R, Marlingue M, Ravis E, Lagier D et al (2017) Expressions of adenosine A2A receptors in coronary arteries and peripheral blood mononuclear cells are correlated in coronary artery disease patients. Int J Cardiol 230:427–431

Article  PubMed  Google Scholar 

Gessi S, Cattabriga E, Avitabile A, Gafa R, Lanza G, Cavazzini L et al (2004) Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 10(17):5895–901

Article  CAS  PubMed  Google Scholar 

Gessi S, Merighi S, Sacchetto V, Simioni C, Borea PA (2011) Adenosine receptors and cancer. Biochimica et Biophysica Acta (BBA)-Biomembranes 1808(5):1400–12

Article  CAS  PubMed  Google Scholar 

Hatfield SM, Sitkovsky M (2016) A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer. Curr Opin Pharmacol 29:90–96

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hinz S, Navarro G, Borroto-Escuela D, Seibt BF, Ammon Y-C, De Filippo E et al (2018) Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors. Oncotarget 9(17):13593

Article  PubMed  PubMed Central  Google Scholar 

Inoue Y, Yoshimura K, Kurabe N, Kahyo T, Kawase A, Tanahashi M et al (2017) Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Oncotarget 8(5):8738–8751

Article  PubMed  PubMed Central  Google Scholar 

Jafari SM, Joshaghani HR, Panjehpour M, Aghaei M, Zargar BN (2017) Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44+ and CD24- breast cancer stem cells. Cell Prolif 50(4):e12345

Article  PubMed  PubMed Central  Google Scholar 

Kazemi MH, RaoofiMohseni S, Hojjat-Farsangi M, Anvari E, Ghalamfarsa G, Mohammadi H et al (2018) Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer. J Cell Physiol 233(3):2032–2057

Article  CAS  PubMed  Google Scholar 

Khoo H-E, Ho C-L, Chhatwal VJ, Chan ST, Ngoi S-S, Moochhala SM (1996) Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. Cancer Lett 106(1):17–21

Article  CAS  PubMed  Google Scholar 

Kukulski F, Lévesque SA, Sévigny J (2011) Impact of ectoenzymes on p2 and p1 receptor signaling. Adv Pharmacol 61:263–299

Article  CAS  PubMed  Google Scholar 

Lukashev D, Ohta A, Sitkovsky M (2007) Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 26(2):273–279

Article  CAS  PubMed  Google Scholar 

Ma D-F, Kondo T, Nakazawa T, Niu D-F, Mochizuki K, Kawasaki T et al (2010) Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells. Hum Pathol 41(11):1550–1557

Article  CAS  PubMed  Google Scholar 

Merighi S, Mirandola P, Milani D, Varani K, Gessi S, Klotz K-N et al (2002) Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Investig Dermatol 119(4):923–933

Article  CAS  PubMed  Google Scholar 

Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG et al (2003) A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Ther 100(1):31–48

Article  CAS  PubMed  Google Scholar 

Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E et al (2005) A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 280(20):19516–19526

Article  CAS  PubMed  Google Scholar 

Merighi S, Battistello E, Giacomelli L, Varani K, Vincenzi F, Borea PA et al (2019) Targeting A3 and A2A adenosine receptors in the fight against cancer. Expert Opin Ther Targets 23(8):669–678

Article  CAS  PubMed  Google Scholar 

Mirza A, Basso A, Black S, Malkowski M, Kwee L, Patcher JA et al (2005) RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis. Cancer Biol Ther 4(12):1355–1360

Article  CAS  PubMed  Google Scholar 

Morello S, Petrella A, Festa M, Popolo A, Monaco M, Vuttariello E et al (2008) Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Cancer Biol Ther 7(2):278–284

Article  CAS  PubMed  Google Scholar 

Mousavi S, Panjehpour M, Izadpanahi MH, Aghaei M (2015) Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues. Prostate 75(7):735–747

Article  CAS  PubMed